NLRP3 inflammasome in depression: A review

Area of Science:

• Neuroimmunology
• Molecular Biology
• Pharmacology

Background:

• Inflammation and cytokine release are key factors in depression pathophysiology.
• The NLRP3 inflammasome (NLRP3) is implicated in chronic inflammatory diseases, including depression-like conditions.

Purpose of the Study:

• To elucidate the role of NLRP3 inflammasome in depression-like chronic diseases.
• To review therapeutic strategies targeting NLRP3 activation pathways for depression management.

Main Methods:

• Review of preclinical and clinical research studies on NLRP3 inflammasome in depression.
• Analysis of NLRP3 activation pathways and their inhibition.

Main Results:

• NLRP3 inflammasome activation contributes significantly to the inflammatory processes in depression.
• Targeting NLRP3 pathways shows potential for therapeutic intervention in depression.

Conclusions:

• Blocking NLRP3 inflammasome action is crucial for mitigating inflammatory cytokine release that exacerbates depression.
• NLRP3 inhibitors represent a promising avenue for the treatment of depression.